2026 PANP360 Immersive Philadelphia

At the completion of this activity, participants should be better able to:

• Categorize the pathology and mechanism of action of therapies for atopic dermatitis, psoriasis and hidradenitis suppurativa.

• Compare therapeutic options for inflammatory conditions like atopic dermatitis, psoriasis and hidradenitis suppurativa.

• Apply varying diagnostic tools to alopecia case examples.

• Discuss clinical data regarding the role of glucagon-like peptide-1 (GLP-1) receptor agonists in psoriasis with the aim to troubleshoot utilization challenges and provide patient education.

• Recognize the clinical presentation and how to optimize treatment for patients with hidradenitis suppurativa, psoriasis and atopic dermatitis.

• Appraise and implement evidence-based management strategies for common dermatologic conditions through case-based discussions, hands-on practice, and collaborative problem-solving.